超声萤火虫联合超微血管成像技术对比X线钼靶诊断乳腺疾病的价值

冯淑; 李阳; 靳鹏; 汤晓敏; 孙医学

doi:10.16766/j.cnki.issn.1674-4152.002246

超声萤火虫联合超微血管成像技术对比X线钼靶诊断乳腺疾病的价值

doi: 10.16766/j.cnki.issn.1674-4152.002246

冯淑¹,
李阳¹,
靳鹏¹,
汤晓敏²,
孙医学^1, ,

1.
蚌埠医学院第一附属医院超声医学科，安徽蚌埠 233004
2.
蚌埠医学院第一附属医院放射科，安徽蚌埠 233004

基金项目:

安徽省教育厅重点项目 KJ2020A0582

蚌埠医学院自然科学研究重点项目 BYKY2019113ZD

详细信息

通讯作者:
孙医学，E-mail：13309621158@163.com

中图分类号: R445.1R737.9
计量
- 文章访问数: 249
- HTML全文浏览量: 71
- PDF下载量: 7
- 被引次数: 0
出版历程
- 收稿日期: 2021-08-04

Value of micropure combined with superb microvascular imaging compared with X-ray molybdenum target for the diagnosis of breast diseases

1.
Department of Ultrasound Medicine, the First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, China

摘要

摘要: 目的探讨超声萤火虫成像联合超微血管成像检查对比X线钼靶检查技术在诊断乳腺良恶性疾病中的鉴别价值。方法选取2019年12月—2020年12月在蚌埠医学院第一附属医院治疗的女性乳腺疾病患者160例，其中良性病变为124例，恶性病变为36例。所有乳腺疾病患者均为单发病变，所有纳入的乳腺疾病患者均接受超声萤火虫成像联合超微血管成像检查及X线钼靶检查技术。以术后的病理结果为金标准，比较2种检查技术的诊断结果和在乳腺疾病中的诊断效能。结果 160例乳腺疾病患者，超声萤火虫成像联合超微血管成像检查诊断检出率为97.2%，X线钼靶检查诊断检出率为77.8%，2组间差异有统计学意义(P < 0.05)。超声萤火虫成像联合超微血管成像检查技术诊断特异度为95.2%(118/124)、灵敏度为97.2%(35/36)、准确度为95.6%(153/160)均高于X线钼靶检查技术[特异度78.2%(97/124)、灵敏度77.8%(28/36)、准确度78.1%(125/160)]，差异有统计学意义(χ²=15.415、4.571、21.487，均P < 0.05)。结论超声萤火虫成像联合超微血管成像检查技术诊断乳腺疾病的效能高于X线钼靶单项检查技术，有助于提高乳腺恶性肿瘤的诊断准确率。
- 乳腺疾病 /
- 超声萤火虫成像 /
- 超微血管成像 /
- X线钼靶 /
- 诊断价值
Abstract: Objective To explore the value of micropure combined with superb microvascular imaging compared with X-ray mammography in the diagnosis of benign and malignant breast diseases. Methods A total of 160 female patients with breast diseases, who were admitted to the First Affiliated Hospital of Bengbu Medical College from December 2019 to December 2020, were selected, of which 124 were benign lesions and 36 were malignant lesions. All patients with breast diseases were single lesions, and all included patients with breast diseases received micropure combined with superb microvascular imaging examination and X-ray molybdenum target. Postoperative pathological results were used as the gold standard to compare the diagnostic efficacy of micropure combined with superb microvascular imaging and X-ray molybdenum target in breast diseases. Results Amongst the 160 patients with breast diseases, the diagnostic detection rate of micropure combined with superb microvascular imaging was 97.2%, whereas the diagnostic detection rate of X-ray molybdenum target was 77.8%, and the difference between the two groups was statistically significant (P < 0.05). The diagnostic specificity of 95.2% (118/124), sensitivity of 97.2% (35/36) and accuracy of 95.6% (153/160) for micropure combined with superb microvascular imaging were higher than those for X-ray molybdenum target [specificity of 78.2% (97/124), sensitivity of 77.8% (28/36) and accuracy of 78.1% (125/160)] by 15.415 (specificity), 4.571 (sensitivity) and 21.487 (accuracy), respectively, and the difference was statistically significant (all P < 0.05). Conclusion The efficacy of micropure combined with superb microvascular imaging for diagnosing breast diseases is higher than that of X-ray molybdenum target alone, which is conducive to improving the diagnostic accuracy of breast malignant tumours.
- Breast disease /
- Micropure /
- Superb microvascular imaging /
- X-ray molybdenum target /
- Diagnostic value
利益冲突 无

HTML全文

图 1 乳腺浸润性导管癌SMI成像图

注：血流分级为Ⅱ级。

下载: 全尺寸图片幻灯片

图 2 乳腺浸润性导管癌SMI成像图

注：血流分级为Ⅱ级。

下载: 全尺寸图片幻灯片

图 3 钙化灶的显示情况

注：左侧为乳腺浸润性导管癌高频超声模式下钙化灶的显示情况，右侧为萤火虫成像模式下微钙化灶的显示情况。

下载: 全尺寸图片幻灯片

表 1 micropure联合SMI诊断乳腺疾病良恶性结果比较(例)

病理检查	micropure联合SMI		合计
病理检查	良性	恶性	合计
良性	118	6	124
恶性	1	35	36
合计	119	41	160

下载: 导出CSV

表 2 X线钼靶诊断乳腺疾病良恶性结果比较(例)

病理检查	X线钼靶		合计
病理检查	良性	恶性	合计
良性	97	27	124
恶性	8	28	36
合计	105	55	160

下载: 导出CSV

表 3 2种检测方法的特异度、灵敏度、准确度比较(%)

项目	灵敏度	特异度	准确度
Micropure联合SMI	97.2(35/36)	95.2(118/124)	95.6(153/160)
X线钼靶	77.8(28/36)	78.2(97/124)	78.1(125/160)
χ²值	4.571	15.415	21.487
P值	0.033	< 0.001	< 0.001

下载: 导出CSV

参考文献(20)

[1]	REHBERG B, MATHIVON S, COMBESCURE C, et al. Prediction of acute postoperative pain following breast cancer surgery using the pain sensitivity questionnaire: A cohort study[J]. Clin J Pain, 2017, 33(1): 57-66. doi: 10.1097/AJP.0000000000000380
[2]	王祥芝, 汤晓敏, 杨菊萍, 等. 数字乳腺断层摄影与MRI在乳腺良恶性疾病诊断中的比较[J]. 中华全科医学, 2021, 19(7): 1186-1190. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202107031.htm
[3]	罗青, 陈伟萍, 郭黎红, 等. 超声"萤火虫"联合超微血管成像技术校正BI-RADS 4级乳腺结节的临床价值[J]. 实用医学杂志, 2019, 35(15): 2474-2477. doi: 10.3969/j.issn.1006-5725.2019.15.026
[4]	李茂谊, 罗琴音, 陈琛, 等. BI-RADS分类联合超微血管成像技术在乳腺实性结节鉴别诊断中的价值[J]. 中国现代医生, 2020, 58(4): 136-138. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDYS202004050.htm
[5]	姜玉新, 张运. 超声医学高级教程[M]. 北京: 中华医学电子音像出版社, 2016: 395-396.
[6]	顾星. 超声"萤火虫"成像及常规高频超声在乳腺微钙化中的研究[J]. 南通大学学报(医学版), 2020, 40(1): 81-83. https://www.cnki.com.cn/Article/CJFDTOTAL-NTYX202001022.htm
[7]	GUO R, LU G, QIN B, et al. Ultrasound imaging technologies for breast cancer detection and management: A Review[J]. Ultrasound Med Biol, 2018, 44(1): 37-70. https://pubmed.ncbi.nlm.nih.gov/29107353/
[8]	赵青, 纪甜甜, 赵献萍, 等. 超声与钼靶BI-RADS分类对不同直径乳腺肿块的诊断价值的对比研究[J]. 影像研究与医学应用, 2018, 2(6): 160-161. doi: 10.3969/j.issn.2096-3807.2018.06.094
[9]	BHELE S, STODDART L, PETERSEN C et al. Parasitic microcalcifications of the breast[J]. Int J Surg Pathol, 2020, 28(6): 645-646. doi: 10.1177/1066896919894687
[10]	HORVAT J V, KEATING D M, Rodrigues-Duarte H, et al. Calcifications at digital breast tomosynthesis: Imaging features and biopsy techniques[J]. Radiographics, 2019, 39(2): 307-318. doi: 10.1148/rg.2019180124
[11]	吴水才, 欧阳亚丽, 崔博翔, 等. 乳腺微钙化超声检测方法综述[J]. 北京工业大学学报, 2020, 46(2): 217-226. https://www.cnki.com.cn/Article/CJFDTOTAL-BJGD202002013.htm
[12]	杨真露, 李嫣, 詹晨奥, 等. RSNA2020乳腺影像学[J]. 放射学实践, 2021, 36(3): 307-310. https://www.cnki.com.cn/Article/CJFDTOTAL-FSXS202103010.htm
[13]	王月红, 温德惠, 刘翔宇, 等. 超声MicroPure成像技术联合mSMI对TI-RADS3、4级结节的鉴别诊断价值[J]. 临床耳鼻咽喉头颈外科杂志, 2017, 31(3): 180-184, 190. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH201703004.htm
[14]	RUAN W, HE Y, SHAO X, et al. The ability of micropure^® ultrasound technique to identify microcalcifications in carotid plaques[J]. Clin Neurol Neurosurg, 2021, 201: 106401. doi: 10.1016/j.clineuro.2020.106401
[15]	YANG Y, MU T, LI T, et al. Effects of FSTL1 on the proliferation and motility of breast cancer cells and vascular endothelial cells[J]. Thorac Cancer, 2017, 8(6): 606-612. doi: 10.1111/1759-7714.12491
[16]	BARR R G, COSSROVE D, BROCK M, et al. WFUMB guidelines and recommendations on the clinical use of ultrasound elastography: Part 5. Prostate[J]. Ultrasound Med Biol, 2017, 43(1): 27-48. doi: 10.1016/j.ultrasmedbio.2016.06.020
[17]	CHEN L, ZHAN J, DIAO X H, et al. Additional value of superb microvascular imaging for thyroid nodule classification with the thyroid imaging reporting and data system[J]. Ultrasound Med Biol, 2019, 45(8): 2040-2048. doi: 10.1016/j.ultrasmedbio.2019.05.001
[18]	LIM A K P, SATCHITHANANDA K, DICK E A, et al. Microflow imaging: New doppler technology to detect low-grade inflammation in patients with arthritis[J]. Eur Radiol, 2018, 28(3): 1046-1053. doi: 10.1007/s00330-017-5016-4
[19]	STRAND F, HUMPHRAEYS K, ERIKSSON M, et al. Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancer[J]. Int J Cancer, 2017, 140(1): 34-40. doi: 10.1002/ijc.30427
[20]	DIAO X, ZHAN J, CHEN L, et al. Role of superb microvascular imaging in differentiating between malignant and benign solid breast masses[J]. Clin Breast Cancer, 2020, 20(6): e786-e793. doi: 10.1016/j.clbc.2020.06.009